JP2025142338A5 - - Google Patents

Info

Publication number
JP2025142338A5
JP2025142338A5 JP2025127530A JP2025127530A JP2025142338A5 JP 2025142338 A5 JP2025142338 A5 JP 2025142338A5 JP 2025127530 A JP2025127530 A JP 2025127530A JP 2025127530 A JP2025127530 A JP 2025127530A JP 2025142338 A5 JP2025142338 A5 JP 2025142338A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
solid pharmaceutical
meloxicam
composition according
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025127530A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025142338A (ja
Filing date
Publication date
Priority claimed from JP2021016747A external-priority patent/JP7017275B2/ja
Application filed filed Critical
Publication of JP2025142338A publication Critical patent/JP2025142338A/ja
Publication of JP2025142338A5 publication Critical patent/JP2025142338A5/ja
Pending legal-status Critical Current

Links

JP2025127530A 2015-11-25 2025-07-30 メロキシカムを含む固体医薬組成物 Pending JP2025142338A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562259993P 2015-11-25 2015-11-25
US62/259,993 2015-11-25
JP2021016747A JP7017275B2 (ja) 2015-11-25 2021-02-04 メロキシカムを含む固体医薬組成物
JP2022007214A JP7332202B2 (ja) 2015-11-25 2022-01-20 メロキシカムを含む固体医薬組成物
JP2023126893A JP7721602B2 (ja) 2015-11-25 2023-08-03 メロキシカムを含む固体医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023126893A Division JP7721602B2 (ja) 2015-11-25 2023-08-03 メロキシカムを含む固体医薬組成物

Publications (2)

Publication Number Publication Date
JP2025142338A JP2025142338A (ja) 2025-09-30
JP2025142338A5 true JP2025142338A5 (cg-RX-API-DMAC7.html) 2026-03-17

Family

ID=60389519

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2017560488A Active JP6746612B2 (ja) 2015-11-25 2016-04-11 メロキシカムを含む医薬組成物
JP2019074133A Active JP6842122B2 (ja) 2015-11-25 2019-04-09 メロキシカムを含む医薬組成物
JP2021016747A Active JP7017275B2 (ja) 2015-11-25 2021-02-04 メロキシカムを含む固体医薬組成物
JP2022007214A Active JP7332202B2 (ja) 2015-11-25 2022-01-20 メロキシカムを含む固体医薬組成物
JP2023126893A Active JP7721602B2 (ja) 2015-11-25 2023-08-03 メロキシカムを含む固体医薬組成物
JP2025127530A Pending JP2025142338A (ja) 2015-11-25 2025-07-30 メロキシカムを含む固体医薬組成物

Family Applications Before (5)

Application Number Title Priority Date Filing Date
JP2017560488A Active JP6746612B2 (ja) 2015-11-25 2016-04-11 メロキシカムを含む医薬組成物
JP2019074133A Active JP6842122B2 (ja) 2015-11-25 2019-04-09 メロキシカムを含む医薬組成物
JP2021016747A Active JP7017275B2 (ja) 2015-11-25 2021-02-04 メロキシカムを含む固体医薬組成物
JP2022007214A Active JP7332202B2 (ja) 2015-11-25 2022-01-20 メロキシカムを含む固体医薬組成物
JP2023126893A Active JP7721602B2 (ja) 2015-11-25 2023-08-03 メロキシカムを含む固体医薬組成物

Country Status (23)

Country Link
US (1) US9821075B2 (cg-RX-API-DMAC7.html)
EP (3) EP4008319B1 (cg-RX-API-DMAC7.html)
JP (6) JP6746612B2 (cg-RX-API-DMAC7.html)
KR (9) KR102465027B1 (cg-RX-API-DMAC7.html)
CN (2) CN107405359B (cg-RX-API-DMAC7.html)
AU (4) AU2016218992C1 (cg-RX-API-DMAC7.html)
CA (4) CA3011562C (cg-RX-API-DMAC7.html)
CY (1) CY1125193T1 (cg-RX-API-DMAC7.html)
DK (1) DK3256138T3 (cg-RX-API-DMAC7.html)
ES (1) ES2913288T3 (cg-RX-API-DMAC7.html)
HU (1) HUE058677T2 (cg-RX-API-DMAC7.html)
IL (3) IL316648A (cg-RX-API-DMAC7.html)
LT (1) LT3256138T (cg-RX-API-DMAC7.html)
MX (2) MX380762B (cg-RX-API-DMAC7.html)
MY (1) MY191574A (cg-RX-API-DMAC7.html)
NZ (1) NZ734233A (cg-RX-API-DMAC7.html)
PL (1) PL3256138T3 (cg-RX-API-DMAC7.html)
PT (1) PT3256138T (cg-RX-API-DMAC7.html)
RS (1) RS63260B1 (cg-RX-API-DMAC7.html)
SG (2) SG10202010157VA (cg-RX-API-DMAC7.html)
SI (1) SI3256138T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202200194T1 (cg-RX-API-DMAC7.html)
WO (1) WO2016131067A2 (cg-RX-API-DMAC7.html)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10821181B2 (en) 2015-02-10 2020-11-03 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10729774B1 (en) 2015-02-10 2020-08-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10780165B2 (en) 2015-02-10 2020-09-22 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11110173B2 (en) 2015-02-10 2021-09-07 Axsome Therapeutics, Inc Pharmaceutical compositions comprising meloxicam
US11045549B2 (en) 2015-02-10 2021-06-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10517950B1 (en) 2015-02-10 2019-12-31 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10537642B1 (en) 2015-02-10 2020-01-21 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10722583B2 (en) 2015-02-10 2020-07-28 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10729773B2 (en) 2015-02-10 2020-08-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10653777B2 (en) 2015-02-10 2020-05-19 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10058614B2 (en) 2015-02-10 2018-08-28 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10695429B2 (en) 2015-02-10 2020-06-30 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US12485176B2 (en) 2015-02-10 2025-12-02 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10695430B2 (en) 2015-02-10 2020-06-30 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11607456B2 (en) 2015-02-10 2023-03-21 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10933137B2 (en) 2015-02-10 2021-03-02 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10933136B2 (en) 2015-02-10 2021-03-02 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11738085B2 (en) 2015-02-10 2023-08-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11013806B2 (en) 2015-02-10 2021-05-25 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10532101B1 (en) 2015-02-10 2020-01-14 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11602563B2 (en) 2015-02-10 2023-03-14 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10702602B2 (en) 2015-02-10 2020-07-07 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
SG10202010157VA (en) * 2015-02-10 2020-11-27 Axsome Therapeutics Inc Pharmaceutical compositions comprising meloxicam
US10758618B2 (en) 2015-02-10 2020-09-01 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10512692B2 (en) 2015-02-10 2019-12-24 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10799588B2 (en) 2015-02-10 2020-10-13 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10780166B2 (en) 2015-02-10 2020-09-22 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11013805B2 (en) 2015-02-10 2021-05-25 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11806354B2 (en) 2017-01-04 2023-11-07 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11266657B2 (en) 2017-01-04 2022-03-08 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10583144B2 (en) 2017-01-04 2020-03-10 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11207327B2 (en) 2017-01-04 2021-12-28 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11801250B2 (en) 2017-01-04 2023-10-31 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10905693B2 (en) 2017-01-04 2021-02-02 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10821182B2 (en) 2017-06-29 2020-11-03 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11617755B2 (en) 2017-01-04 2023-04-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10561664B1 (en) 2017-01-04 2020-02-18 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11433078B2 (en) 2017-01-04 2022-09-06 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
DK3565550T3 (da) 2017-01-04 2021-01-18 Axsome Therapeutics Inc Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan
US10471014B2 (en) 2017-01-04 2019-11-12 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10894053B2 (en) 2017-01-04 2021-01-19 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10729697B2 (en) 2017-01-04 2020-08-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11433079B2 (en) 2017-01-04 2022-09-06 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11471465B2 (en) 2017-01-04 2022-10-18 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10583088B2 (en) 2017-01-04 2020-03-10 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10940153B2 (en) 2017-01-04 2021-03-09 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10729696B2 (en) 2017-01-04 2020-08-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
KR102583443B1 (ko) * 2017-05-10 2023-09-26 액섬 테라퓨틱스, 인크. 멜록시캄을 포함하는 약학적 조성물
US11219626B2 (en) 2017-06-29 2022-01-11 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11617756B2 (en) 2017-06-29 2023-04-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10758617B2 (en) 2017-06-29 2020-09-01 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10688185B2 (en) 2017-06-29 2020-06-23 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11617791B2 (en) 2017-06-29 2023-04-04 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10688102B2 (en) 2017-06-29 2020-06-23 Axsome Therapeutics, Inc. Combination treatment for migraine and other pain
US10512693B2 (en) 2017-06-29 2019-12-24 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11759522B2 (en) 2017-06-29 2023-09-19 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11510927B2 (en) 2017-06-29 2022-11-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10987358B2 (en) 2017-06-29 2021-04-27 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11185550B2 (en) 2017-06-29 2021-11-30 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US10918722B2 (en) 2017-06-29 2021-02-16 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US11865117B2 (en) 2017-06-29 2024-01-09 Axsome Therapeutics, Inc Pharmaceutical compositions comprising meloxicam
US12691123B2 (en) 2017-06-29 2026-07-28 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
WO2019143560A1 (en) * 2018-01-16 2019-07-25 The Regents Of The University Of California Methods for promoting mitochondrial biogenesis in neural cells
KR102006777B1 (ko) 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
KR102080023B1 (ko) 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
CR20210061A (es) * 2018-07-03 2021-03-18 Axsome Therapeutics Inc Composiciones farmacéuticas que comprenden meloxicam
JP2021533177A (ja) 2018-08-23 2021-12-02 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む、優れた溶解特性を備えた薬学的製剤
WO2020069138A1 (en) * 2018-09-28 2020-04-02 Axsome Therapeutics, Inc. Dosage forms comprising active pharmaceutical ingredients
MY198967A (en) * 2019-02-06 2023-10-05 Axsome Therapeutics Inc Pharmaceutical compositions comprising meloxicam
BR112022001287A2 (pt) * 2019-07-26 2022-04-12 Chong Kun Dang Pharmaceutical Corp Composição farmacêutica
US20240058354A1 (en) 2020-04-06 2024-02-22 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US12128052B2 (en) 2020-05-28 2024-10-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US20250352552A1 (en) * 2020-11-06 2025-11-20 Mylan Laboratories Ltd Pharmaceutical composition comprising meloxicam
US12648912B2 (en) * 2020-11-06 2026-06-09 Mylan Laboratories Limited Pharmaceutical composition comprising meloxicam
CN116437902A (zh) * 2020-11-06 2023-07-14 迈兰实验室有限公司 包含美洛昔康的医药组成物
JP7495340B2 (ja) * 2020-12-16 2024-06-04 株式会社ファンケル カルノシン酸含有固体組成物及びカルノシン酸の溶出促進方法
KR20230125826A (ko) 2020-12-31 2023-08-29 액섬 테라퓨틱스, 인크. 멜록시캄을 포함하는 약학 조성물
US12370196B2 (en) 2020-12-31 2025-07-29 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
CA3217139A1 (en) * 2021-04-27 2022-11-03 Sang-Jin Lee Composition for preventing or treating muscular disease, comprising oxicam-based compound
US12005118B2 (en) 2022-05-19 2024-06-11 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising meloxicam
US12544383B1 (en) 2025-01-30 2026-02-10 Axsome Therapeutics, Inc. Methods of treating migraines with a combination of a meloxicam and a rizatriptan
US12697341B1 (en) 2025-05-07 2026-08-04 Viatris Inc. Methods of using meloxicam for pain treatment and management

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3343295A (en) 1994-08-12 1996-03-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridine salt
EP0775120B1 (en) 1994-08-13 2003-06-04 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
KR20010023256A (ko) * 1997-08-27 2001-03-26 헥살 아게 용해도와 생체 이용성이 개선된 신규의 멜록시캄 의약조성물
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
DK1411900T4 (da) * 2001-06-01 2014-01-27 Pozen Inc Farmaceutiske sammensætninger til den koordinerede frigørelse af NSAIDs
WO2005004915A2 (en) * 2003-07-09 2005-01-20 Boehringer Ingelheim International Gmbh Compositions comprising meloxicam
GB0320382D0 (en) * 2003-08-30 2003-10-01 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Pharmaceutical compositions
WO2005027807A1 (en) 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
EP1718303A4 (en) 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
US9016221B2 (en) 2004-02-17 2015-04-28 University Of Florida Research Foundation, Inc. Surface topographies for non-toxic bioadhesion control
WO2005105102A1 (en) 2004-05-04 2005-11-10 Equitech Corporation Improved nsaid composition
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
US20070281927A1 (en) 2006-06-06 2007-12-06 Shanthakumar Tyavanagimatt Anti-inflammatory and analgesic compositions and related methods
WO2008006216A1 (en) 2006-07-14 2008-01-17 Mistral Pharma, Inc. Anti-inflammatory and cytoprotectant chronotherapy
RU2009131454A (ru) * 2007-01-19 2011-02-27 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств
CN101686681B (zh) * 2007-04-27 2015-04-01 锡德克斯药物公司 包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法
AU2008265595B2 (en) * 2007-06-20 2014-12-04 PureTech LYT 100 Inc. Substituted N-Aryl pyridinones as fibrotic inhibitors
PL3100728T3 (pl) * 2009-05-13 2020-05-18 Cydex Pharmaceuticals, Inc. Kompozycje farmaceutyczne zawierające prasugrel i pochodne cyklodekstryny oraz sposoby ich wytwarzania i zastosowania
CN101987081B (zh) 2010-07-16 2012-08-08 钟术光 一种控释制剂
HUE045889T2 (hu) * 2010-10-21 2020-01-28 Rtu Pharmaceuticals Llc Használatkész ketorolak készítmények
DE102010052847A1 (de) 2010-11-29 2012-05-31 Temmler Werke Gmbh Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung
CN102526058A (zh) * 2010-12-28 2012-07-04 秦引林 一种含氯诺昔康和埃索美拉唑消炎镇痛药物组合物
WO2014161131A1 (en) * 2013-04-01 2014-10-09 Arissa Pharma PREPARING AMORPHOUS MELOXICAM-β-CYCLODEXTRIN INCLUSION COMPLEX VIA SPRAY DRYING PROCESS
SG10202010157VA (en) 2015-02-10 2020-11-27 Axsome Therapeutics Inc Pharmaceutical compositions comprising meloxicam

Similar Documents

Publication Publication Date Title
JP2019131596A5 (cg-RX-API-DMAC7.html)
JP6266075B2 (ja) 味覚マスキングのためのイオン交換樹脂を含有する可食性経口ストリップ又はウエハース剤形
JP2024075655A5 (ja) 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用
JP2024517738A5 (cg-RX-API-DMAC7.html)
TW200815048A (en) Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
UA79075C2 (uk) Фармацевтична композиція, що містить гіалуронову кислоту та гліцерритинову кислоту, та її застосування
JPH01501143A (ja) 爪への薬物の施用のための皮膜形成性製剤用ヴェヒクル、これらのヴェヒクルを基にした薬剤組成物および同じものの使用法
EP1898925A2 (en) Method for the treatment of acne
JP2021520400A (ja) エダラボン医薬組成物
BR112019027286B1 (pt) Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva
CA3127926A1 (en) Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
FR2735369A1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
Sheoran Buccal drug delivery system: A review
JP2022132446A (ja) 低中毒性抗コリン作動性エステルのための方法および組成物
JP2002534477A5 (cg-RX-API-DMAC7.html)
JP2022177119A5 (cg-RX-API-DMAC7.html)
MXPA02007788A (es) Composicion farmaceutica para inyeccion intramuscular conteniendo loxoprofeno.
JPH08295637A (ja) 口腔部局所投与剤
JP2008542290A (ja) 皮膚狼瘡の治療又は予防のための4−[(シクロプロパンカルボニルアミノ)メチル]−2−(2,6−ジオキソピペリジン−3−イル)イソインドール−1,3−ジオンの使用方法及び組成物
JP6940279B2 (ja) 注腸剤
US20040029843A1 (en) Rapidly disintegrating formulations for treating or preventing mucositis
TWI897768B (zh) 阿哌沙班膜產品用於治療血栓症之用途
WO2008038423A1 (fr) Composition antiphlogistique et analgésique pour une utilisation orale
WO2016102708A1 (en) Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol
JP2009507850A5 (cg-RX-API-DMAC7.html)